- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07296133
GAMES Intervention in MCI (Mild Cognitive Impairment)
Evaluating Online Gameplay Intervention to Support Social Engagement in Older Adults With and Without Mild Cognitive Impairment (MCI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kayci Vickers, PhD
- Phone Number: (404) 712-4849
- Email: kayci.lynne.vickers@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50 to 85 years old
- Living independently (note: can live in assisted living, but must have independently complete daily activities)
- Fluent in English
- Adequate visual and auditory acuity to see/hear computer screen
- MoCA-Blind (converted to MoCA score) > 17
Additional Criteria for MCI Group:
- Existing diagnosis by HC professional
- MoCA-Blind (converted to MoCA score) of 18-25
- FAQ < 9
Exclusion Criteria:
- Cognitive impairment secondary to stroke, TBI or other neurological cause without concern for neurodegenerative condition (e.g., Alzheimer's disease, vascular dementia, etc.)
- Medical illnesses that would prevent participation
- Major psychiatric disturbance meeting DSM V criteria in last year
- Hx of substance abuse within last two years
- Current psychoactive med use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online Gameplay Intervention Group
Participants will receive:
|
-The online gameplay intervention includes playing online versions of common games (such as Connect 4 and Uno) with a partner, 3 times per week for at least 15 minutes, for 12 weeks. All games will be delivered via a novel online platform (OneClick; developed by PotLuck, LLC) created specifically to support and enhance social engagement with family members and close friends.
|
|
Other: Wait-list control Group
Participants will receive:
|
- Participants will be informed that study team will contact them once per week by telephone for 12 weeks, to ask about social activities they completed in the week prior.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in friendship Scale score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
The scale consists of 5 core items, each with a 5-point frequency response (Almost always to Not at all). Total possible score range is 5-25. Higher scores indicate greater feelings of social isolation (worse study outcome). |
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
|
Change in UCLA Loneliness Scale score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
This is a self -report scale with 20 items. Participants rate each item on a 4-point Likert scale: (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often). Total possible score ranges from 20 to 80, with higher scores indicating greater perceived loneliness (worse study outcome). |
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
|
Change in Neuro-QOL score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
Neuro-QOL ("Quality of Life in Neurological Disorders") consists of a scale designed to measure health-related quality of life across a variety of neurological conditions.
The abbreviated form comprises short forms (8-10 items each) covering 13 key domains: physical, mental, and social health.
Response format for each item ranges from "Never" to "Always" or severity levels like "None" to "Cannot do".
Scores are summarized and represented with T-scores (mean = 50, SD = 10), derived from their respective calibrated item questionnaire.
Higher scores correlate with worse outcome.
|
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
|
Change in meaning and purpose score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
This scale measures an individual's sense of meaning, purpose, and life satisfaction.
Includes 8-9 items in the short form, with statements like "My life has meaning" or "I have a sense of purpose," rated on a 5-point (from 1=never to 5=always).
Scores are expressed as T-scores (mean = 50, SD = 10).
Higher scores represent better outcome (more positive well-being).
|
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tech Experience and Comfort scale score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
Measures confidence in using new or everyday technologies, reflecting both comfort and perceived ability. Includes 10 items, each beginning with the stem "I could use the new technology…". Participant will rate confidence on a 10-point scale (e.g., from "Not at all confident" to "Completely confident"). Total possible score range is 10-100, with better score correlating with greater confidence/comfort in using technology. |
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
|
Change in Perceived Stress score
Time Frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
Measures the degree to which situations in one's life are appraised as stressful. This is a 10-item scale that focuses on feelings of unpredictability, lack of control, and overload during the past month. Response format is with a 5-point Likert scale (0 = Never, 1 = Almost never, 2 = Sometimes, 3 = Fairly often, 4 = Very often). Total score range is 0-40. Higher scores correlate with greater perceived stress (worse outcome). |
Pre-intervention (Baseline), week 6 and post-intervention (week 12)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kayci Vickers, PhD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025P011653
- 1R44AG078009-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Data will be shared with researchers who provide a methodologically sound proposal, to achieve aims in approved proposal.
Proposals should be directed to kvicker@emory.edu. To gain access, data requestors will need to sign a data access agreement. Data will be made available for 5 years.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Singapore General HospitalSingapore Health ServicesNot yet recruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment
-
Xuanwu Hospital, BeijingNot yet recruitingMild Cognitive Impairment (MCI)China
-
The Hong Kong Polytechnic UniversityJohns Hopkins University; The University of Hong Kong; University of ReadingNot yet recruitingMild Cognitive Impairment (MCI)Hong Kong
-
Universidad Complutense de MadridAB Biotics, SANot yet recruitingMild Cognitive Impairment (MCI)Spain
-
University of SheffieldNot yet recruitingMild Cognitive Impairment (MCI)United Kingdom
-
The Hong Kong Polytechnic UniversityRecruitingMild Cognitive Impairment (MCI)Hong Kong
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.TerminatedMild Cognitive Impairment (MCI)Taiwan
Clinical Trials on Online Gameplay Intervention
-
Neuromotion LabsActive, not recruitingProblem Behavior | Emotional Regulation | Irritable MoodUnited States
-
Neuromotion LabsCompleted
-
Neuromotion LabsCompleted
-
Istanbul UniversityHealth Institutes of TurkeyEnrolling by invitationDuchenne Muscular Dystrophy (DMD)Turkey (Türkiye)
-
Universidad Nacional Autonoma de MexicoNot yet recruitingDepression | Anxiety Disorders | Emotional Disorder | Stress Related DisorderMexico
-
University of SheffieldCompletedVisual FatigueUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationCompletedCancer | Pediatric CancerUnited States
-
University of Vic - Central University of CataloniaRecruitingMultiple SclerosisSpain
-
Seattle Children's HospitalCompletedChronic Pain | Abdominal Pain | HeadacheUnited States
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedMedical and Nursing Students' Evidence Retrieval SkillsCanada